Friday, November 30, 2012 Thursday, November 29, 2012- Usana on the Edge in China, St. Jude Okays Repurchase: Healthcare Business Reportat Wall St. Cheat Sheet (Thu, Nov 29)
- FDA Rejection. EU Withdrawal. Set and Match?at Motley Fool (Thu, Nov 29)
- Two Picks from Cramer's Nov. 27th Lightning Round.at Motley Fool (Thu, Nov 29)
- Neptune's Crisis Could Mean It's Time To Acquire This Speculative Equityat Seeking Alpha (Thu, Nov 29)
- Pfizer to Present Updated Data While Moving the Dowat Wall St. Cheat Sheet (Thu, Nov 29)
- Big Changes Up Ahead for Abbott Investorsat Motley Fool (Thu, Nov 29)
- Generic Lipitor Supply Adequate as Ranbaxy Recalls Pillsat Bloomberg (Thu, Nov 29)
- Is Parexel Int'l Passing The Test For Investors?at Investor's Business Daily (Thu, Nov 29)
- If Only People Would Take Their Meds -- Pharma Sales Might Doubleat Forbes (Thu, Nov 29)
- Mylan selling generic version of Pfizer's DetrolAP (Thu, Nov 29)
- SAC’s Villhauer Said to Be Head Trader Cited in U.S. Caseat Bloomberg (Thu, Nov 29)
- NVS Discusses Data Readout PlansZacks (Thu, Nov 29)
- Has Eli Lilly Become the Perfect Stock?at Motley Fool (Thu, Nov 29)
- 5 Big Stocks to Trade for Gains This Weekat TheStreet (Thu, Nov 29)
- Billionaire Ken Fisher And Donald Yacktman's Best Investment Ideas For 2013at Seeking Alpha (Thu, Nov 29)
- Pfizer to Present Clinical Data from Its Hematology Portfolio at the 54th Annual Meeting of the American Society of HematologyBusiness Wire (Thu, Nov 29)
Wednesday, November 28, 2012Add PFE News to My Yahoo!   | |
|
0.07(0.24%) May 24, 4:00PM EDT|After Hours
:
29.02